Showing results (231-240 of 2,094) with videos related to

Sort By:
Pageof 210
Ecancermedicalscience|April 23, 2021
A systematic review and meta-analysis of the prevalence of therapeutic targets in cervical cancerMaria Guadalupe Patrono, Maria Florencia Calvo, Juan Victor Ariel Franco, et al.
Ecancermedicalscience|April 23, 2021
Strengthening breast surgery workforce capacity: implementation of competency-based training programmeMaría Eugenia Aponte-Rueda, Maybell Nieves
Ecancermedicalscience|October 6, 2022
Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial CentreSuresh Kumar Bondili, Ravindra Nandhana, Aditya Dhanawat, et al.
Ecancermedicalscience|February 28, 2024
Paediatric fibrosarcoma treatmentAdrián Cano-Padilla, Augusto Ramírez, Paola Cervantes-Rivera, et al.
Ecancermedicalscience|February 28, 2024
LuciA-15 - a real-world prospective study of PARP inhibitors for the treatment of patients with HER-2 negative metastatic breast cancer with germline and/or somatic mutation of BRCA genes or homologous recombination repair related genesFernando E Petracci, Cynthia Villarreal-Garza, Facundo Argañaraz, et al.
Ecancermedicalscience|February 28, 2024
Current scenario and future perspectives of clinical research in Brazil: a national surveyHeloisa Resende, Taiane F Rebelatto, Gustavo Werutsky, et al.
Ecancermedicalscience|February 28, 2024
Assessing the utilization of cancer medicines in Rwanda: an analysis of treatment patternsFidel Rubagumya, Brooke Wilson, Cyprien Shyirambere, et al.
Ecancermedicalscience|March 1, 2024
Sociodemographic and treatment-related correlates of fatigue in breast cancer survivors at an oncology clinic in NigeriaSharif Adeniyi Folorunso, Abbas Adesina Abdus-Salam, Atara Isiah Ntekim, et al.
Ecancermedicalscience|February 28, 2024
EGFR and HER2 expression in cervical cancer patients in Ibadan, NigeriaAjibike Ayomide Orekoya, Abbas A Abdus-Salam, Abdurasaq R Oyesegun, et al.
Ecancermedicalscience|February 28, 2024
Re-challenge of immune checkpoint inhibitor pembrolizumab with concurrent tocilizumab after prior grade 3 pneumonitisChitrakshi Nagpal, Sameer Rastogi, Shamim A Shamim, et al.
Pageof 210